000153322 001__ 153322
000153322 005__ 20240420115849.0
000153322 0247_ $$2doi$$a10.1212/NXG.0000000000000417
000153322 0247_ $$2pmid$$apmid:32337344
000153322 0247_ $$2pmc$$apmc:PMC7164971
000153322 0247_ $$2altmetric$$aaltmetric:78535726
000153322 037__ $$aDZNE-2020-01319
000153322 041__ $$aEnglish
000153322 082__ $$a610
000153322 1001_ $$0P:(DE-HGF)0$$aMol, Merel O$$b0$$eCorresponding author
000153322 245__ $$aClinical and pathologic phenotype of a large family with heterozygous STUB1 mutation.
000153322 260__ $$aMinneapolis, Minn.$$c2020
000153322 3367_ $$2DRIVER$$aarticle
000153322 3367_ $$2DataCite$$aOutput Types/Journal article
000153322 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1713532954_11034
000153322 3367_ $$2BibTeX$$aARTICLE
000153322 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153322 3367_ $$00$$2EndNote$$aJournal Article
000153322 520__ $$aTo describe the clinical and pathologic features of a novel pedigree with heterozygous STUB1 mutation causing SCA48.We report a large pedigree of Dutch decent. Clinical and pathologic data were reviewed, and genetic analyses (whole-exome sequencing, whole-genome sequencing, and linkage analysis) were performed on multiple family members.Patients presented with adult-onset gait disturbance (ataxia or parkinsonism), combined with prominent cognitive decline and behavioral changes. Whole-exome sequencing identified a novel heterozygous frameshift variant c.731_732delGC (p.C244Yfs*24) in STUB1 segregating with the disease. This variant was present in a linkage peak on chromosome 16p13.3. Neuropathologic examination of 3 cases revealed a consistent pattern of ubiquitin/p62-positive neuronal inclusions in the cerebellum, neocortex, and brainstem. In addition, tau pathology was present in 1 case.This study confirms previous findings of heterozygous STUB1 mutations as the cause of SCA48 and highlights its prominent cognitive involvement, besides cerebellar ataxia and movement disorders as cardinal features. The presence of intranuclear inclusions is a pathologic hallmark of the disease. Future studies will provide more insight into its pathologic heterogeneity.
000153322 536__ $$0G:(DE-HGF)POF3-342$$a342 - Disease Mechanisms and Model Systems (POF3-342)$$cPOF3-342$$fPOF III$$x0
000153322 588__ $$aDataset connected to CrossRef, PubMed,
000153322 7001_ $$avan Rooij, Jeroen G J$$b1
000153322 7001_ $$aBrusse, Esther$$b2
000153322 7001_ $$aVerkerk, Annemieke J M H$$b3
000153322 7001_ $$aMelhem, Shamiram$$b4
000153322 7001_ $$aden Dunnen, Wilfred F A$$b5
000153322 7001_ $$0P:(DE-2719)2810718$$aRizzu, Patrizia$$b6$$udzne
000153322 7001_ $$aCupidi, Chiara$$b7
000153322 7001_ $$avan Swieten, John C$$b8
000153322 7001_ $$aDonker Kaat, Laura$$b9
000153322 773__ $$0PERI:(DE-600)2818607-2$$a10.1212/NXG.0000000000000417$$gVol. 6, no. 3, p. e417 -$$n3$$pe417$$tNeurology / Genetics$$v6$$x2376-7839$$y2020
000153322 8564_ $$uhttps://pub.dzne.de/record/153322/files/DZNE-2020-01319.pdf$$yOpenAccess
000153322 8564_ $$uhttps://pub.dzne.de/record/153322/files/DZNE-2020-01319.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000153322 909CO $$ooai:pub.dzne.de:153322$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000153322 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810718$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000153322 9131_ $$0G:(DE-HGF)POF3-342$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vDisease Mechanisms and Model Systems$$x0
000153322 9141_ $$y2020
000153322 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-29
000153322 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROL-GENET : 2021$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-13T18:57:06Z
000153322 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-29
000153322 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-13T18:57:06Z
000153322 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000153322 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-02-13T18:57:06Z
000153322 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-08-29
000153322 915__ $$0LIC:(DE-HGF)CCBYNCNDNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)$$bDOAJ$$d2020-08-29
000153322 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-29
000153322 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-25
000153322 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-08-29
000153322 9201_ $$0I:(DE-2719)1210009$$kAG Rizzu$$lApplied Genomics for Neurodegenerative Diseases$$x0
000153322 980__ $$ajournal
000153322 980__ $$aVDB
000153322 980__ $$aUNRESTRICTED
000153322 980__ $$aI:(DE-2719)1210009
000153322 9801_ $$aFullTexts